VDPHL01 is an investigational drug, currently in Phase 2/3 testing. It has no marketing authorisation in any country, and no pharmacy is legally allowed to sell it.
Why this matters
Unauthorised products may contain inactive or harmful substances.
Using unapproved drugs can delay evidence-based treatment and jeopardise trial data.
Purchasing or importing unregistered medicines may violate local law.
How to recognise authorised supply (future)
Check that the pharmacy appears on the official Veradermics Verified Partner List (will be published here after approval).
Look for national regulatory authorisation numbers (e.g. NDC for the US, EU/1/… for EMA).
Verify tamper-evident packaging and QR-code traceability.
Purchase only with a valid prescription issued by a licensed clinician.
Current evidence-based options
Until VDPHL01 completes clinical development, the following approved therapies remain the mainstay of care. You can order them via the trusted partner pharmacies listed below.
